LUNG — Pulmonx Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1127537 ·
Last close
$1.63
Market Cap
$68.85M
52W High
$1.85
52W Low
$1.17
ADV30
631,802
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 20,586,000 | 16,044,000 | -12,956,000 | -13,654,000 | 119,966,000 | 61,572,000 | 74,205,000 |
| Dec 2025 | 22,598,000 | 17,541,000 | -9,903,000 | -10,425,000 | 129,291,000 | 69,751,000 | 75,175,000 |
| Sep 2025 | 21,502,000 | 16,052,000 | -14,393,000 | -13,957,000 | 138,281,000 | 76,549,000 | 78,248,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-29,251,000
Investing CF
$14,160,000
Financing CF
$2,195,000
CapEx
$-160,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-535,212,000
Inventory
$16,310,000
Receivables
$11,271,000
ST Investments
$0
EBIT TTM
$-49,219,000
Pretax Income TTM
$-52,569,000
Interest Exp TTM
$3,350,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$87,442,000
EBITDA
$-45,592,000
Free Cash Flow
$-8,362,750
Enterprise Value
$68,742,704
Total Cash
$55,843,000
Total Debt
$56,211,000
Shares Out
42,237,203
Trailing EPS
$-1.15
Book Value
$1.08
ROE
-88.9%
ROA
-22.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 90,497,000 | -53,663,000 | -54,003,000 | 129,291,000 | 75,175,000 | — | -32,376,000 |
| Dec 2024 | 83,789,000 | -57,704,000 | -56,394,000 | 162,850,000 | 77,041,000 | — | -31,537,000 |
| Dec 2023 | 68,675,000 | -61,935,000 | -60,843,000 | 177,781,000 | 59,466,000 | — | -37,610,000 |
| Dec 2022 | 53,662,000 | -58,637,000 | -58,923,000 | 193,676,000 | 39,669,000 | — | -45,083,000 |
TTM Snapshot
Revenues TTM
$64,818,000
NetIncome TTM
$-53,397,000
OpCashFlow TTM
$0
Assets (Latest)
$162,850,000
Forward EPS
$-0.96
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | $68.20M | $0.98 | — |
| DRIO | DarioHealth Corp. | $70.88M | $7.27 | — |
| STEX | Streamex Corp. | $74.02M | $0.71 | — |
| RTGN | RetinalGenix Technologies Inc. | $75.37M | $4.00 | — |
| HCIL | Hongchang International Co., Ltd | $62.26M | $0.12 | — |
News headlines (Yahoo Finance, 1h cache)
Pulmonx Corporation Q2 2026 Earnings Call Summary
2026-07-30 12:30 · Yahoo
Pulmonx Q2 Earnings Call Highlights
2026-07-29 23:04 · Yahoo
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
2026-07-29 21:25 · Yahoo
Pulmonx Reports Second Quarter 2026 Financial Results
2026-07-29 20:05 · Yahoo
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
2026-07-28 20:05 · Yahoo
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
2026-07-15 20:05 · Yahoo
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-01 20:05 · Yahoo
Pulmonx (LUNG) Q1 2026 Earnings Transcript
2026-04-30 16:25 · Yahoo
Pulmonx Corporation Q1 2026 Earnings Call Summary
2026-04-30 12:30 · Yahoo
Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
2026-04-30 07:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.